Ferring Makes Foray Into Gene Therapy With FKD Pact – Scrip
Scrip |
Ferring Makes Foray Into Gene Therapy With FKD Pact
Scrip Executive Summary. The Swiss company's CMO Klaus Dugi tells Scrip that getting the rights to a late-stage bladder cancer gene therapy from Finland's FKD highlights the transformation that Ferring is undergoing. Already Registered? Sign in to continue … |
